Direct‐acting antivirals for chronic hepatitis C

BACKGROUND: Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive interventions for chronic hepatitis C, and preliminary results suggest that DAAs may e...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cochrane Database Syst Rev
मुख्य लेखकों: Jakobsen, Janus C, Nielsen, Emil Eik, Feinberg, Joshua, Katakam, Kiran Kumar, Fobian, Kristina, Hauser, Goran, Poropat, Goran, Djurisic, Snezana, Weiss, Karl Heinz, Bjelakovic, Milica, Bjelakovic, Goran, Klingenberg, Sarah Louise, Liu, Jian Ping, Nikolova, Dimitrinka, Koretz, Ronald L, Gluud, Christian
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley & Sons, Ltd 2017
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484376/
https://ncbi.nlm.nih.gov/pubmed/28922704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012143.pub3
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन